Miriam Kidron Oramed Pharmaceuticals Inc. (ORMP) insider trading activity
Miriam Kidron is Chief Scientific Officer of ORAMED PHARMACEUTICALS INC.. Currently has a direct ownership of 1.19 Million shares of ORMP, which is worth approximately $2.49 Million. The most recent transaction as insider was on Feb 11, 2025, when has been sold 192,667 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.19M
50.36%
3M change
56.26%
12M change
Total Value Held
$2.49 Million
Miriam Kidron Transaction History
MK
Miriam Kidron
Chief Scientific Officer
Jerusalem, L3